Marica has spent the past two decades building and leading high-performing technology and product development teams. At CareDx, Marica held roles of increasing leadership and management responsibilities and is currently accountable for strategy and operational oversight of the Cell Transplant Therapy business unit and Pharma Partnerships. Earlier in her career, Marica spearheaded the development of AlloSure®, the first analytically and clinically validated cell-free DNA test developed specifically for transplant patients. Prior to CareDx, Marica was a founding scientist at the stem cell-based drug discovery platform technology company iPierian (acquired by BMS), and its spin out True North Therapeutics (acquired by Bioverativ).
Marica completed her post-doctoral fellowship on gene regulation in stem cells at University of California San Francisco (UCSF) and holds a PhD in Molecular Biology and Biochemistry from European Molecular Biology Laboratory (EMBL) and University of Heidelberg, Germany.